{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:47:34Z","timestamp":1782805654230,"version":"3.54.5"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL154757"],"award-info":[{"award-number":["HL154757"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI143256"],"award-info":[{"award-number":["AI143256"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI143256"],"award-info":[{"award-number":["AI143256"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA290808-01"],"award-info":[{"award-number":["CA290808-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA254897"],"award-info":[{"award-number":["P50 CA254897"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA254897"],"award-info":[{"award-number":["P50 CA254897"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    In graft-versus-host disease (GVHD), Ca\n                    <jats:sup>2+<\/jats:sup>\n                    signals in alloreactive T cells are carefully controlled to determine whether cells survive or thrive, although how this is accomplished during GVHD remains poorly defined. We demonstrate that EZH2, a chromatin-modifying enzyme, promotes alloreactive T-cell survival in GVHD by acting as a Ca\n                    <jats:sup>2+<\/jats:sup>\n                    signaling brake to limit excessive intracellular Ca\n                    <jats:sup>2+<\/jats:sup>\n                    responses.\n                    <jats:italic>Ezh2<\/jats:italic>\n                    loss led to the upregulation of gene programs that promote effector differentiation in activated T cells, coincident with enhanced intracellular Ca\n                    <jats:sup>2+<\/jats:sup>\n                    responses that ultimately caused massive cell death. Conditional deletion of\n                    <jats:italic>Stim1<\/jats:italic>\n                    (required for cytosolic Ca\n                    <jats:sup>2+<\/jats:sup>\n                    entry) led to \u201csynthetic rescue\u201d of\n                    <jats:italic>Ezh2<\/jats:italic>\n                    -null T cells by protecting them from cell death without interfering with effector differentiation, resulting in severe GVHD. Interestingly,\n                    <jats:italic>Stim1<\/jats:italic>\n                    expression was unaffected by EZH2, whereas the expression of the endoplasmic reticulum Ca\n                    <jats:sup>2+<\/jats:sup>\n                    release channel inositol 1,4,5-trisphosphate receptor 2 (\n                    <jats:italic>Itpr2<\/jats:italic>\n                    ) was suppressed by EZH2. Notably, EZH2 and Ca\n                    <jats:sup>2+<\/jats:sup>\n                    signals served mutually opposing roles in controlling the expression of genes in chimeric antigen receptor (CAR) T cells. Inhibiting Ca\u00b2\u207a signaling restored EZH2 function in CAR-T cells, significantly improving their antitumor activity. Our findings reveal the interdependent roles of EZH2 and Ca\n                    <jats:sup>2+<\/jats:sup>\n                    signals in coordinating antigen-activated T-cell responses that mediate alloimmunity and tumor immunity.\n                  <\/jats:p>","DOI":"10.1038\/s41423-026-01413-y","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T09:22:10Z","timestamp":1776849730000},"page":"840-854","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["EZH2 and intracellular Ca2+ signals interdependently coordinate alloreactive and CAR-T-cell responses"],"prefix":"10.1038","volume":"23","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingrong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruqayyah","family":"Sanders-Braggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Pomerantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Clando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woonbok","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2258-5030","authenticated-orcid":false,"given":"Jean-Pierre J.","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5192-1297","authenticated-orcid":false,"given":"Jonathan","family":"Soboloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"1413_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nri3212","volume":"12","author":"BR Blazar","year":"2012","unstructured":"Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol. 2012;12:443\u201358.","journal-title":"Nat Rev Immunol"},{"key":"1413_CR2","doi-asserted-by":"crossref","unstructured":"Socie G, Kean LS, Zeiser R, Blazar BR. Insights from integrating clinical and preclinical studies advance understanding of graft-versus-host disease. J Clin Investig. 2021;131:e149296.","DOI":"10.1172\/JCI149296"},{"key":"1413_CR3","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMra1609337","volume":"377","author":"R Zeiser","year":"2017","unstructured":"Zeiser R, Blazar BR. Acute graft-versus-host disease - biologic process, prevention, and therapy. N Engl J Med. 2017;377:2167\u201379.","journal-title":"N Engl J Med"},{"key":"1413_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cophys.2020.07.016","volume":"17","author":"Y Wang","year":"2020","unstructured":"Wang Y, Tao A, Vaeth M, Feske S. Calcium regulation of T-cell metabolism. Curr Opin Physiol. 2020;17:207\u201323.","journal-title":"Curr Opin Physiol"},{"key":"1413_CR5","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.tibs.2023.08.006","volume":"48","author":"S Gross","year":"2023","unstructured":"Gross S, Womer L, Kappes DJ, Soboloff J. Multifaceted control of T-cell differentiation by STIM1. Trends Biochem Sci. 2023;48:1083\u201397.","journal-title":"Trends Biochem Sci"},{"key":"1413_CR6","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nrm3414","volume":"13","author":"J Soboloff","year":"2012","unstructured":"Soboloff J, Rothberg BS, Madesh M, Gill DL. STIM proteins: dynamic calcium signal transducers. Nat Rev Mol Cell Biol. 2012;13:549\u201365.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1413_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41577-018-0110-7","volume":"19","author":"M Trebak","year":"2019","unstructured":"Trebak M, Kinet JP. Calcium signaling in T cells. Nat Rev Immunol. 2019;19:154\u201369.","journal-title":"Nat Rev Immunol"},{"key":"1413_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1182\/blood.2023019875","volume":"142","author":"H Senjo","year":"2023","unstructured":"Senjo H, Harada S, Kubota SI, Tanaka Y, Tateno T, Zhang Z, et al. Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT. Blood. 2023;142:477\u201392.","journal-title":"Blood"},{"key":"1413_CR9","doi-asserted-by":"crossref","unstructured":"Wang Y, Ullah MA, Waltner OG, Bhise SS, Ensbey KS, Schmidt CR, et al. Calcineurin inhibition rescues alloantigen-specific central memory T-cell subsets that promote chronic GVHD. J Clin Investig. 2024; 134:e170125.","DOI":"10.1172\/JCI170125"},{"key":"1413_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1182\/blood.2019000032","volume":"135","author":"G Thangavelu","year":"2020","unstructured":"Thangavelu G, Du J, Paz KG, Loschi M, Zaiken MC, Flynn R, et al. Inhibition of inositol kinase B controls acute and chronic graft-versus-host disease. Blood. 2020;135:28\u201340.","journal-title":"Blood"},{"key":"1413_CR11","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.cell.2008.12.043","volume":"136","author":"E Ezhkova","year":"2009","unstructured":"Ezhkova E, Pasolli HA, Parker JS, Stokes N, Su IH, Hannon G, et al. Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. Cell. 2009;136:1122\u201335.","journal-title":"Cell"},{"key":"1413_CR12","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.1182\/blood-2010-04-280149","volume":"116","author":"I Velichutina","year":"2010","unstructured":"Velichutina I, Shaknovich R, Geng H, Johnson NA, Gascoyne RD, Melnick AM, et al. EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis. Blood. 2010;116:5247\u201355.","journal-title":"Blood"},{"key":"1413_CR13","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1182\/blood-2005-09-3585","volume":"107","author":"LM Kamminga","year":"2006","unstructured":"Kamminga LM, Bystrykh LV, de Boer A, Houwer S, Douma J, Weersing E, et al. The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion. Blood. 2006;107:2170\u20139.","journal-title":"Blood"},{"key":"1413_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature09784","volume":"469","author":"R Margueron","year":"2011","unstructured":"Margueron R, Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature. 2011;469:343\u20139.","journal-title":"Nature"},{"key":"1413_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature11606","volume":"492","author":"MT McCabe","year":"2012","unstructured":"McCabe MT, Ott HM, Ganji G, Korenchuk S, Thompson C, Van Aller GS, et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature. 2012;492:108\u201312.","journal-title":"Nature"},{"key":"1413_CR16","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1182\/blood-2010-11-321208","volume":"117","author":"DB Yap","year":"2010","unstructured":"Yap DB, Chu J, Berg T, Schapira M, Cheng SW, Moradian A, et al. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood. 2010;117:2451\u20139.","journal-title":"Blood"},{"key":"1413_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ng.518","volume":"42","author":"RD Morin","year":"2010","unstructured":"Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R, et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet. 2010;42:181\u201395.","journal-title":"Nat Genet"},{"key":"1413_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02187-8","volume":"8","author":"S He","year":"2017","unstructured":"He S, Liu Y, Meng L, Sun H, Wang Y, Ji Y, et al. Ezh2 phosphorylation state determines its capacity to maintain CD8(+) T memory precursors for antitumor immunity. Nat Commun. 2017;8:2125.","journal-title":"Nat Commun"},{"key":"1413_CR19","doi-asserted-by":"publisher","first-page":"5012","DOI":"10.4049\/jimmunol.1302943","volume":"192","author":"Q Tong","year":"2014","unstructured":"Tong Q, He S, Xie F, Mochizuki K, Liu Y, Mochizuki I, et al. Ezh2 regulates transcriptional and posttranslational expression of t-bet and promotes Th1 cell responses mediating aplastic anemia in mice. J Immunol. 2014;192:5012\u201322.","journal-title":"J Immunol"},{"key":"1413_CR20","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1182\/blood-2013-05-505180","volume":"122","author":"S He","year":"2013","unstructured":"He S, Xie F, Liu Y, Tong Q, Mochizuki K, Lapinski PE, et al. The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease. Blood. 2013;122:4119\u201328.","journal-title":"Blood"},{"key":"1413_CR21","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.immuni.2013.09.012","volume":"39","author":"DJ Tumes","year":"2013","unstructured":"Tumes DJ, Onodera A, Suzuki A, Shinoda K, Endo Y, Iwamura C, et al. The polycomb protein Ezh2 regulates differentiation and plasticity of CD4(+) T helper type 1 and type 2 cells. Immunity. 2013;39:819\u201332.","journal-title":"Immunity"},{"key":"1413_CR22","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.immuni.2017.03.012","volume":"46","author":"SM Gray","year":"2017","unstructured":"Gray SM, Amezquita RA, Guan T, Kleinstein SH, Kaech SM. Polycomb Repressive Complex 2-mediated chromatin repression guides effector CD8(+) T-cell terminal differentiation and loss of multipotency. Immunity. 2017;46:596\u2013608.","journal-title":"Immunity"},{"key":"1413_CR23","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1182\/blood-2013-12-544106","volume":"124","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Kinkel S, Maksimovic J, Bandala-Sanchez E, Tanzer MC, Naselli G, et al. The polycomb repressive complex 2 governs the life and death of peripheral T cells. Blood. 2014;124:737\u201349.","journal-title":"Blood"},{"key":"1413_CR24","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1172\/JCI80273","volume":"125","author":"L Desvignes","year":"2015","unstructured":"Desvignes L, Weidinger C, Shaw P, Vaeth M, Ribierre T, Liu M, et al. STIM1 controls T-cell-mediated immune regulation and inflammation in chronic infection. J Clin Invest. 2015;125:2347\u201362.","journal-title":"J Clin Invest"},{"key":"1413_CR25","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1113\/JP271139","volume":"594","author":"DL Prole","year":"2016","unstructured":"Prole DL, Taylor CW. Inositol 1,4,5-trisphosphate receptors and their protein partners as signaling hubs. J Physiol. 2016;594:2849\u201366.","journal-title":"J Physiol"},{"key":"1413_CR26","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.bbamcr.2018.11.007","volume":"1866","author":"NB Thillaiappan","year":"2019","unstructured":"Thillaiappan NB, Chakraborty P, Hasan G, Taylor CW. IP(3) receptors and Ca(2+) entry. Biochim Biophys Acta Mol Cell Res. 2019;1866:1092\u20131100.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"1413_CR27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.pharmthera.2018.07.001","volume":"192","author":"T Pathak","year":"2018","unstructured":"Pathak T, Trebak M. Mitochondrial Ca(2+) signaling. Pharmacol Ther. 2018;192:112\u201323.","journal-title":"Pharmacol Ther"},{"key":"1413_CR28","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.4049\/jimmunol.1100847","volume":"187","author":"KD Kim","year":"2011","unstructured":"Kim KD, Srikanth S, Yee MK, Mock DC, Lawson GW, Gwack Y. ORAI1 deficiency impairs activated T-cell death and enhances T-cell survival. J Immunol. 2011;187:3620\u201330.","journal-title":"J Immunol"},{"key":"1413_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/bs.ircmb.2018.07.004","volume":"342","author":"J Spetz","year":"2019","unstructured":"Spetz J, Presser AG, Sarosiek KA. T cells and regulated cell death: kill or be killed. Int Rev Cell Mol Biol. 2019;342:27\u201371.","journal-title":"Int Rev Cell Mol Biol"},{"key":"1413_CR30","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/emboj.2011.495","volume":"31","author":"MF Ritchie","year":"2012","unstructured":"Ritchie MF, Samakai E, Soboloff J. STIM1 is required for attenuation of PMCA-mediated Ca2+ clearance during T-cell activation. EMBO J. 2012;31:1123\u201333.","journal-title":"EMBO J"},{"key":"1413_CR31","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.it.2020.06.012","volume":"41","author":"M Vaeth","year":"2020","unstructured":"Vaeth M, Kahlfuss S, Feske S. CRAC channels and calcium signaling in T-Cell-mediated immunity. Trends Immunol. 2020;41:878\u2013901.","journal-title":"Trends Immunol"},{"key":"1413_CR32","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1182\/blood-2016-08-735886","volume":"129","author":"Q Huang","year":"2017","unstructured":"Huang Q, He S, Tian Y, Gu Y, Chen P, Li C, et al. Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in mice. Blood. 2017;129:2737\u201348.","journal-title":"Blood"},{"key":"1413_CR33","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.4049\/jimmunol.0802888","volume":"182","author":"N Beyersdorf","year":"2009","unstructured":"Beyersdorf N, Braun A, V\u00f6gtle T, Varga-Szabo D, Galdos RR, Kissler S, et al. STIM1-independent T-cell development and effector function in vivo. J Immunol. 2009;182:3390\u20137.","journal-title":"J Immunol"},{"key":"1413_CR34","doi-asserted-by":"crossref","unstructured":"Alimadadi A, Munroe PB, Joe B, Cheng X. Meta-analysis of dilated cardiomyopathy using cardiac RNA-seq transcriptomic datasets. Genes 2020;11:60.","DOI":"10.3390\/genes11010060"},{"key":"1413_CR35","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nmeth884","volume":"3","author":"L Nolden","year":"2006","unstructured":"Nolden L, Edenhofer F, Haupt S, Koch P, Wunderlich FT, Siemen H, et al. Site-specific recombination in human embryonic stem cells induced by cell-permeant Cre recombinase. Nat Methods. 2006;3:461\u20137.","journal-title":"Nat Methods"},{"key":"1413_CR36","doi-asserted-by":"publisher","first-page":"10 34 11","DOI":"10.1002\/0471142735.im1034s105","volume":"105","author":"S Sharma","year":"2014","unstructured":"Sharma S, Zhu J. Immunologic applications of conditional gene modification technology in the mouse. Curr Protoc Immunol. 2014;105:10 34 11\u201310 34 13.","journal-title":"Curr Protoc Immunol"},{"key":"1413_CR37","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41590-025-02089-8","volume":"26","author":"L Zhong","year":"2025","unstructured":"Zhong L, Wang YH, Kahlfuss S, Jishage M, McDermott M, Yang J, et al. STIM1-mediated NFAT signaling synergizes with STAT1 to control T-bet expression and T(H)1 differentiation. Nat Immunol. 2025;26:484\u201396.","journal-title":"Nat Immunol"},{"key":"1413_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1146\/annurev-physiol-022724-105627","volume":"87","author":"V Arige","year":"2025","unstructured":"Arige V, MacLean DM, Yule DI. Inositol 1,4,5-trisphosphate receptor mutations associated with human disease: insights into receptor function and dysfunction. Annu Rev Physiol. 2025;87:201\u201328.","journal-title":"Annu Rev Physiol"},{"key":"1413_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5814","volume":"5","author":"K Ouyang","year":"2014","unstructured":"Ouyang K, Leandro Gomez-Amaro R, Stachura DL, Tang H, Peng X, Fang X, et al. Loss of IP3R-dependent Ca2+ signaling in thymocytes leads to aberrant development and acute lymphoblastic leukemia. Nat Commun. 2014;5:4814.","journal-title":"Nat Commun"},{"key":"1413_CR40","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/cmi.2015.32","volume":"13","author":"JG Crompton","year":"2016","unstructured":"Crompton JG, Narayanan M, Cuddapah S, Roychoudhuri R, Ji Y, Yang W, et al. Lineage relationship of CD8(+) T-cell subsets is revealed by progressive changes in the epigenetic landscape. Cell Mol Immunol. 2016;13:502\u201313.","journal-title":"Cell Mol Immunol"},{"key":"1413_CR41","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.coi.2013.09.003","volume":"25","author":"NP Restifo","year":"2013","unstructured":"Restifo NP, Gattinoni L. Lineage relationship of effector and memory T cells. Curr Opin Immunol. 2013;25:556\u201363.","journal-title":"Curr Opin Immunol"},{"key":"1413_CR42","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1158\/1535-7163.MCT-13-0773","volume":"13","author":"SK Knutson","year":"2014","unstructured":"Knutson SK, Kawano S, Minoshima Y, Warholic NM, Huang KC, Xiao Y, et al. Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma. Mol Cancer Ther. 2014;13:842\u201354.","journal-title":"Mol Cancer Ther"},{"key":"1413_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1166\/msr.2018.1075","volume":"6","author":"LE Terry","year":"2018","unstructured":"Terry LE, Alzayady KJ, Furati E, Yule DI. Inositol 1,4,5-trisphosphate receptor mutations associated with human disease. Messenger. 2018;6:29\u201344.","journal-title":"Messenger"},{"key":"1413_CR44","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/hep.30839","volume":"71","author":"P Ueasilamongkol","year":"2020","unstructured":"Ueasilamongkol P, Khamphaya T, Guerra MT, Rodrigues MA, Gomes DA, Kong Y, et al. Type 3 inositol 1,4,5-trisphosphate receptor is increased and enhances malignant properties in cholangiocarcinoma. Hepatology. 2020;71:583\u201399.","journal-title":"Hepatology"},{"key":"1413_CR45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1084\/jem.184.1.159","volume":"184","author":"JA Garcia-Sanz","year":"1996","unstructured":"Garcia-Sanz JA, Lenig D. Translational control of interleukin 2 messenger RNA as a molecular mechanism of T-cell anergy. J Exp Med. 1996;184:159\u201364.","journal-title":"J Exp Med"},{"key":"1413_CR46","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1182\/blood.V98.10.3156","volume":"98","author":"S Maury","year":"2001","unstructured":"Maury S, Salomon B, Klatzmann D, Cohen JL. Division rate and phenotypic differences discriminate alloreactive and nonalloreactive T cells transferred in lethally irradiated mice. Blood. 2001;98:3156\u20138.","journal-title":"Blood"},{"key":"1413_CR47","doi-asserted-by":"publisher","first-page":"6756","DOI":"10.4049\/jimmunol.0901711","volume":"184","author":"T Onoe","year":"2010","unstructured":"Onoe T, Kalscheuer H, Chittenden M, Zhao G, Yang YG, Sykes M. Homeostatic expansion and phenotypic conversion of human T cells depend on peripheral interactions with APCs. J Immunol. 2010;184:6756\u201365.","journal-title":"J Immunol"},{"key":"1413_CR48","doi-asserted-by":"publisher","first-page":"893545","DOI":"10.3389\/fimmu.2022.893545","volume":"13","author":"L Dekker","year":"2022","unstructured":"Dekker L, Sanders E, Lindemans CA, de Koning C, Nierkens S. Na\u00efve T cells in graft versus host disease and graft versus leukemia: innocent or guilty? Front Immunol. 2022;13:893545.","journal-title":"Front Immunol"},{"key":"1413_CR49","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.immuni.2023.01.003","volume":"56","author":"F Sacirbegovic","year":"2023","unstructured":"Sacirbegovic F, G\u00fcnther M, Greco A, Zhao D, Wang X, Zhou M, et al. Graft-versus-host disease is locally maintained in target tissues by resident progenitor-like T cells. Immunity. 2023;56:369\u201385.","journal-title":"Immunity"},{"key":"1413_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17991-y","volume":"11","author":"M Zhou","year":"2020","unstructured":"Zhou M, Sacirbegovic F, Zhao K, Rosenberger S, Shlomchik WD. T-cell exhaustion and a failure in antigen presentation drive resistance to the graft-versus-leukemia effect. Nat Commun. 2020;11:4227.","journal-title":"Nat Commun"},{"key":"1413_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21045-2","volume":"12","author":"P Tall\u00f3n de Lara","year":"2021","unstructured":"Tall\u00f3n de Lara P, Casta\u00f1\u00f3n H, Vermeer M, N\u00fa\u00f1ez N, Silina K, Sobottka B, et al. CD39(+)PD-1(+)CD8(+) T cells mediate metastatic dormancy in breast cancer. Nat Commun. 2021;12:769.","journal-title":"Nat Commun"},{"key":"1413_CR52","doi-asserted-by":"publisher","first-page":"12410","DOI":"10.1073\/pnas.1905675116","volume":"116","author":"H Seo","year":"2019","unstructured":"Seo H, Chen J, Gonz\u00e1lez-\u00c1valos E, Samaniego-Castruita D, Das A, Wang YH, et al. TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8(+) T-cell exhaustion. Proc Natl Acad Sci USA. 2019;116:12410\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1413_CR53","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.immuni.2008.12.009","volume":"30","author":"G Wei","year":"2009","unstructured":"Wei G, Wei L, Zhu J, Zang C, Hu-Li J, Yao Z, et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity. 2009;30:155\u201367.","journal-title":"Immunity"},{"key":"1413_CR54","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.immuni.2009.05.006","volume":"30","author":"Y Araki","year":"2009","unstructured":"Araki Y, Wang Z, Zang C, Wood WH, Schones D, Cui K, et al. Genome-wide analysis of histone methylation reveals chromatin state-based regulation of gene transcription and function of memory CD8+ T cells. Immunity. 2009;30:912\u201325.","journal-title":"Immunity"},{"key":"1413_CR55","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.immuni.2014.11.001","volume":"41","author":"BE Russ","year":"2014","unstructured":"Russ BE, Olshanksy M, Smallwood HS, Li J, Denton AE, Prier JE, et al. Distinct epigenetic signatures delineate transcriptional programs during virus-specific CD8(+) T-cell differentiation. Immunity. 2014;41:853\u201365.","journal-title":"Immunity"},{"key":"1413_CR56","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.4049\/jimmunol.180.3.1309","volume":"180","author":"NS Joshi","year":"2008","unstructured":"Joshi NS, Kaech SM. Effector CD8 T-cell development: a balancing act between memory cell potential and terminal differentiation. J Immunol. 2008;180:1309\u201315.","journal-title":"J Immunol"},{"key":"1413_CR57","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/ni.3031","volume":"15","author":"JT Chang","year":"2014","unstructured":"Chang JT, Wherry EJ, Goldrath AW. Molecular regulation of effector and memory T-cell differentiation. Nat Immunol. 2014;15:1104\u201315.","journal-title":"Nat Immunol"},{"key":"1413_CR58","doi-asserted-by":"crossref","unstructured":"Weber EW, Parker KR, Sotillo E, Lynn RC, Anbunathan H, Lattin J, et al. Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling. Science 2021;372:eaba1786.","DOI":"10.1126\/science.aba1786"},{"key":"1413_CR59","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.immuni.2015.01.006","volume":"42","author":"GJ Martinez","year":"2015","unstructured":"Martinez GJ, Pereira RM, \u00c4ij\u00f6 T, Kim EY, Marangoni F, Pipkin ME, et al. The transcription factor NFAT promotes exhaustion of activated CD8(+) T cells. Immunity. 2015;42:265\u201378.","journal-title":"Immunity"},{"key":"1413_CR60","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pupt.2007.09.003","volume":"21","author":"K Ohga","year":"2008","unstructured":"Ohga K, Takezawa R, Yoshino T, Yamada T, Shimizu Y, Ishikawa J. The suppressive effects of YM-58483\/BTP-2, a store-operated Ca2+ entry blocker, on inflammatory mediator release in vitro and airway responses in vivo. Pulm Pharmacol Ther. 2008;21:360\u20139.","journal-title":"Pulm Pharmacol Ther"},{"key":"1413_CR61","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ccell.2015.09.004","volume":"28","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Condomines M, van der Stegen S, Perna F, Kloss CC, Gunset G, et al. Structural design of engineered costimulation determines tumor rejection kinetics and persistence of CAR T cells. Cancer Cell. 2015;28:415\u201328.","journal-title":"Cancer Cell"},{"key":"1413_CR62","doi-asserted-by":"publisher","first-page":"102759","DOI":"10.1016\/j.ceca.2023.102759","volume":"113","author":"N Dhaouadi","year":"2023","unstructured":"Dhaouadi N, Vitto VAM, Pinton P, Galluzzi L, Marchi S. Ca(2+) signaling and cell death. Cell Calcium. 2023;113:102759.","journal-title":"Cell Calcium"},{"key":"1413_CR63","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/nm1326","volume":"11","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Joe G, Hexner E, Zhu J, Emerson SG. Host-reactive CD8+ memory stem cells in graft-versus-host disease. Nat Med. 2005;11:1299\u2013305.","journal-title":"Nat Med"},{"key":"1413_CR64","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.4049\/jimmunol.174.5.3051","volume":"174","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Joe G, Hexner E, Zhu J, Emerson SG. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease. J Immunol. 2005;174:3051\u20138.","journal-title":"J Immunol"},{"key":"1413_CR65","doi-asserted-by":"publisher","first-page":"856","DOI":"10.4049\/jimmunol.1002195","volume":"186","author":"D Zhao","year":"2011","unstructured":"Zhao D, Young JS, Chen YH, Shen E, Yi T, Todorov I, et al. Alloimmune response results in expansion of autoreactive donor CD4+ T cells in transplants that can mediate chronic graft-versus-host disease. J Immunol. 2011;186:856\u201368.","journal-title":"J Immunol"},{"key":"1413_CR66","doi-asserted-by":"crossref","unstructured":"Wang Y, et al. Tissue-infiltrating Alloreactive T cells require Id3 to deflect PD-1-mediated immune suppression during GVHD. Blood. 2023;143:166\u201377.","DOI":"10.1182\/blood.2023021126"},{"key":"1413_CR67","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13072-018-0242-9","volume":"11","author":"W Mu","year":"2018","unstructured":"Mu W, Starmer J, Yee D, Magnuson T. EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation. Epigenetics Chromatin. 2018;11:71.","journal-title":"Epigenetics Chromatin"},{"key":"1413_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.198","volume":"7","author":"Y Wang","year":"2016","unstructured":"Wang Y, Sun H, Wang J, Wang H, Meng L, Xu C, et al. DNA-PK-mediated phosphorylation of EZH2 regulates the DNA damage-induced apoptosis to maintain T-cell genomic integrity. Cell Death Dis. 2016;7:e2316.","journal-title":"Cell Death Dis"},{"key":"1413_CR69","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1182\/hematology.2024000588","volume":"2024","author":"G Orofino","year":"2024","unstructured":"Orofino G, Vago L. Biology of posttransplant relapse: actionable features. Hematol Am Soc Hematol Educ Program. 2024;2024:736\u201343.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"1413_CR70","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.clml.2024.01.003","volume":"24","author":"A Rischall","year":"2024","unstructured":"Rischall A, Olson A. SOHO state of the art updates and next questions | CTLs for infections following stem cell transplantation. Clin Lymphoma Myeloma Leuk. 2024;24:340\u20137.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"1413_CR71","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","volume":"19","author":"CU Blank","year":"2019","unstructured":"Blank CU, Haining WN, Held W, Hogan PG, Kallies A, Lugli E, et al. Defining \u2018T-cell exhaustion. Nat Rev Immunol. 2019;19:665\u201374.","journal-title":"Nat Rev Immunol"},{"key":"1413_CR72","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41586-019-0985-x","volume":"567","author":"J Chen","year":"2019","unstructured":"Chen J, L\u00f3pez-Moyado IF, Seo H, Lio CJ, Hempleman LJ, Sekiya T, et al. NR4A transcription factors limit CAR T-cell function in solid tumors. Nature. 2019;567:530\u20134.","journal-title":"Nature"},{"key":"1413_CR73","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.aaf2807","volume":"354","author":"KE Pauken","year":"2016","unstructured":"Pauken KE, Sammons MA, Odorizzi PM, Manne S, Godec J, Khan O, et al. Epigenetic stability of exhausted T cells limits the durability of reinvigoration by PD-1 blockade. Science. 2016;354:1160\u20135.","journal-title":"Science"},{"key":"1413_CR74","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13045-023-01504-7","volume":"16","author":"Y Bulliard","year":"2023","unstructured":"Bulliard Y, Andersson BS, Baysal MA, Damiano J, Tsimberidou AM. Reprogramming T-cell differentiation and exhaustion in CAR-T-cell therapy. J Hematol Oncol. 2023;16:108.","journal-title":"J Hematol Oncol"},{"key":"1413_CR75","doi-asserted-by":"crossref","unstructured":"Arcangeli S, Bove C, Mezzanotte C, Camisa B, Falcone L, Manfredi F, et al. CAR T-cell manufacturing from na\u00efve\/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome. J Clin Investig. 2022;132:e150807.","DOI":"10.1172\/JCI150807"},{"key":"1413_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20696-x","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Tong C, Dai H, Wu Z, Han X, Guo Y, et al. Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming. Nat Commun. 2021;12:409.","journal-title":"Nat Commun"},{"key":"1413_CR77","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41590-021-00964-8","volume":"22","author":"H Seo","year":"2021","unstructured":"Seo H, Gonz\u00e1lez-\u00c1valos E, Zhang W, Ramchandani P, Yang C, Lio CJ, et al. BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells. Nat Immunol. 2021;22:983\u201395.","journal-title":"Nat Immunol"},{"key":"1413_CR78","doi-asserted-by":"publisher","first-page":"6081","DOI":"10.1016\/j.cell.2021.11.016","volume":"184","author":"CR Good","year":"2021","unstructured":"Good CR, Aznar MA, Kuramitsu S, Samareh P, Agarwal S, Donahue G, et al. An NK-like CAR T-cell transition in CAR T-cell dysfunction. Cell. 2021;184:6081\u20136100 e6026.","journal-title":"Cell"},{"key":"1413_CR79","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1172\/JCI133215","volume":"130","author":"S Guedan","year":"2020","unstructured":"Guedan S, Madar A, Casado-Medrano V, Shaw C, Wing A, Liu F, et al. Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability. J Clin Investig. 2020;130:3087\u201397.","journal-title":"J Clin Investig"},{"key":"1413_CR80","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1038\/s41591-020-1061-7","volume":"26","author":"Q Deng","year":"2020","unstructured":"Deng Q, Han G, Puebla-Osorio N, Ma M, Strati P, Chasen B, et al. Characteristics of anti-CD19 CAR T-cell infusion products associated with efficacy and toxicity in patients with large B-cell lymphomas. Nat Med. 2020;26:1878\u201387.","journal-title":"Nat Med"},{"key":"1413_CR81","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41586-019-1805-z","volume":"576","author":"RC Lynn","year":"2019","unstructured":"Lynn RC, Weber EW, Sotillo E, Gennert D, Xu P, Good Z, et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature. 2019;576:293\u2013300.","journal-title":"Nature"},{"key":"1413_CR82","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nm.3838","volume":"21","author":"AH Long","year":"2015","unstructured":"Long AH, Haso WM, Shern JF, Wanhainen KM, Murgai M, Ingaramo M, et al. 4-1BB costimulation ameliorates T-cell exhaustion induced by tonic signaling of chimeric antigen receptors. Nat Med. 2015;21:581\u201390.","journal-title":"Nat Med"},{"key":"1413_CR83","doi-asserted-by":"publisher","first-page":"e2103508","DOI":"10.1002\/advs.202103508","volume":"9","author":"M Shao","year":"2022","unstructured":"Shao M, Teng X, Guo X, Zhang H, Huang Y, Cui J, et al. Inhibition of calcium signaling prevents exhaustion and enhances anti-leukemia efficacy of CAR-T cells via SOCE-calcineurin-NFAT and glycolysis pathways. Adv Sci. 2022;9:e2103508.","journal-title":"Adv Sci"},{"key":"1413_CR84","doi-asserted-by":"publisher","first-page":"eabn7336","DOI":"10.1126\/scitranslmed.abn7336","volume":"14","author":"IY Jung","year":"2022","unstructured":"Jung IY, Narayan V, McDonald S, Rech AJ, Bartoszek R, Hong G, et al. BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T-cell stemness and exhaustion. Sci Transl Med. 2022;14:eabn7336.","journal-title":"Sci Transl Med"},{"key":"1413_CR85","doi-asserted-by":"publisher","first-page":"104972","DOI":"10.1016\/j.ebiom.2024.104972","volume":"100","author":"Y Guo","year":"2024","unstructured":"Guo Y, Cheng R, Wang Y, Gonz\u00e1lez ME, Zhang H, Liu Y, et al. Regulation of EZH2 protein stability: new mechanisms, roles in tumorigenesis, and roads to the clinic. EBioMedicine. 2024;100:104972.","journal-title":"EBioMedicine"},{"key":"1413_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2553-6","volume":"11","author":"SQ Wang","year":"2020","unstructured":"Wang SQ, Liu J, Qin J, Zhu Y, Tin VP, Yam J, et al. CAMK2A supported tumor-initiating4 cells of lung adenocarcinoma by upregulating SOX2 through EZH2 phosphorylation. Cell Death Dis. 2020;11:410.","journal-title":"Cell Death Dis"},{"key":"1413_CR87","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1016\/j.bbamcr.2014.03.007","volume":"1843","author":"H Ivanova","year":"2014","unstructured":"Ivanova H, Vervliet T, Missiaen L, Parys JB, De Smedt H, Bultynck G. Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival. Biochim Biophys Acta. 2014;1843:2164\u201383.","journal-title":"Biochim Biophys Acta"},{"key":"1413_CR88","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1182\/blood-2010-03-271940","volume":"117","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Sandy AR, Wang J, Radojcic V, Shan GT, Tran IT, et al. Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease. Blood. 2011;117:299\u2013308.","journal-title":"Blood"},{"key":"1413_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/srep07760","volume":"5","author":"SN Christo","year":"2015","unstructured":"Christo SN, Diener KR, Nordon RE, Brown MP, Griesser HJ, Vasilev K, et al. Scrutinizing calcium flux oscillations in T lymphocytes to deduce the strength of stimulus. Sci Rep. 2015;5:7760.","journal-title":"Sci Rep"},{"key":"1413_CR90","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/bioinformatics\/btp120","volume":"25","author":"C Trapnell","year":"2009","unstructured":"Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics. 2009;25:1105\u201311.","journal-title":"Bioinformatics"},{"key":"1413_CR91","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nbt.2450","volume":"31","author":"C Trapnell","year":"2013","unstructured":"Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL, Pachter L. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol. 2013;31:46\u201353.","journal-title":"Nat Biotechnol"},{"key":"1413_CR92","doi-asserted-by":"publisher","first-page":"101529","DOI":"10.1016\/j.xpro.2022.101529","volume":"3","author":"A Panday","year":"2022","unstructured":"Panday A, Elango R, Willis NA, Scully R. A modified CUT&RUN-seq technique for qPCR analysis of chromatin-protein interactions. STAR Protoc. 2022;3:101529.","journal-title":"STAR Protoc"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01413-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01413-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01413-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:27:12Z","timestamp":1782804432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01413-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":92,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["1413"],"URL":"https:\/\/doi.org\/10.1038\/s41423-026-01413-y","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}